Several reports have shown that CD4+ T-cells have efficacy in ACT either through supporting the direct cytotoxic function of CD8+ T-cells or via indirect CD4+ dependent mechanisms of tumor cell killing [38,39]. The gene discussed is CD4; the disease is neoplasm.